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Asymmetric dimethylarginine (ADMA), an endogenous inhibitor of nitric oxide synthase (NOS), is
mainly metabolized by N
G,N
G-dimethylarginine dimethylaminohydrolase (DDAH). We investigated
whether altered cavernosal ADMA–DDAH metabolism might cause impairment of erection in rat
model of atherosclerosis (AS). Male Sprague–Dawley rats (3 months old) were divided into an AS
group and a normal control (Con) group (n¼20 in each group). The AS rats received AS-prone
treatment (6 weeks of 1% cholesterol diet plus early 2 weeks of N
G-nitro-L-arginine methyl ester
(3mgml
 1 per day) treatment). After 6 weeks, rats underwent cavernosometry measuring the
maximal intracavernosal pressure/mean arterial pressure (ICP/MAP) ratios as a surrogate marker
of erectile function. The amount of cavernosal ADMA was assessed by immunoblot analysis and
correlated with the ICP/MAP. Isoform-specific DDAH expression was compared by immunohis-
tochemistry. Cavernosal DDAH and NOS activity were measured. Cavernosal malondialdehyde
levels were assayed to determine the degree of lipid peroxidation. Compared to the controls, the AS
rats had signs of impaired erectile function. Higher cavernosal ADMA was observed in the AS rats.
The cavernosal ADMA had a moderately negative correlation with the ICP/MAP. Immunohisto-
chemistry revealed the expression of both isoforms was not affected by the presence of AS.
However, significantly diminished DDAH as well as NOS activity was observed in the AS group. In
addition, elevated cavernosal malondialdehyde levels were noted in the AS rats. Our study showed
that decreased cavernosal DDAH activity is the cause of cavernosal ADMA accumulation leading to
reduced cavernosal NOS activity and impairment of erectile function.
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Introduction
Evidence-based data have indicated that erectile
dysfunction (ED) is common in men with chronic
coronary artery disease (CAD).
1,2 The high fre-
quency of ED in this population has suggested that
something associated with the systemic vasculopa-
thy is associated with ED. Damage to the endothe-
lium from smoking, hypertension, hyperlipidemia
and diabetes affects not only the coronary arteries
but also arteries throughout the body, including
those of the corpora cavernosa of the penis.
3 These
conditions are frequently associated with a reduced
endothelium-mediated vasodilation, where nitric
oxide (NO) has a critical function.
4–6 If the bioactiv-
ity of NO is significantly reduced, this could lead to
endothelial dysfunction that contributes to ED
as a result of the atherosclerotic vascular disease.
Therefore, preservation or restoration of NO
bioactivity could be a potential target for ED
treatment, especially in the presence of systemic
atherosclerosis (AS).
Potential contributing abnormality to decrease the
NO bioactivity is increased levels of asymmetric
N
GN
G-dimethyl-L-arginine (ADMA), although the
mechanisms of endothelial dysfunction are likely
multifactorial. By competing with arginine, through
the Y
þ transporter system, ADMA can inhibit all
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with endothelial dysfunction.
7 Elevation of ADMA
has often been observed in patients with various
cardiovascular diseases where endothelial dysfunc-
tion has been identified as the common etiology.
7
ADMA is mainly metabolized by dimethylarginine
dimethylaminohydrolase (DDAH).
8 This enzyme has
two types: type 1 is closely associated with neuronal
NOS and type 2 with endothelial NOS.
7 Recent study
has identified both isoforms in rabbit penile tissue.
9 It
has been reported that either decreased expression of
DDAH or reduced activity of DDAH is responsible for
the elevation of ADMA.
10,11
Given its pharmacological function as a modulator
of NO activity, and the relationship with endothelial
dysfunction, it is likely that ADMA is associated
with the pathogenesis of ED. Several lines of
evidence have suggested the potential relationship
between ADMA and ED, especially in patients with
CADs.
12,13 Intracavernosal injection of ADMA in-
hibits the pressor responses to pelvic nerve stimula-
tion in the corpus cavernosum of anesthetized dogs,
and the inhibitory effect is reversed by L-arginine.
14
Moreover, cavernosal accumulation of ADMA was
observed in a rabbit model of cavernosal ischemia,
which mimicked the ED observed in AS.
15 Taken
together, in ED patients with AS, elevated ADMA is
likely to be found in penile tissues. However, the
function of ADMA in penile erections has not been
to date sufficiently investigated. Moreover, the
reason for ADMA elevation has not been explored.
To clarify these issues, we designed a study to
examine the relationship between penile ADMA
and erectile function in a rat model of AS. In
addition, the mechanism involved in ADMA eleva-
tion was explored in relationship to DDAH.
Materials and methods
Animal groups and treatment protocol
This study was reviewed and approved by the
committee on the ethics of animal experiments,
Seoul National University, College of Medicine, and
was conducted according to the guidelines for
animal experiments of Seoul National University.
A total of 20 male 12-week-old Sprague–Dawley
rats were divided into a normal control (Con) group
and an AS group (n¼10 in each group). While the
Con group was given standard rat chow and
drinking water, the AS group received a 1%
cholesterol diet (CRF-1; Oriental Yeast Co., Osaka,
Japan) for 6 weeks. To elicit intimal changes
associated with AS, we gave the rats N
G-nitro-L-
arginine methyl ester (3mgml
 1) in the drinking
water, initially for 2 weeks as previously de-
scribed.
16 Despite the popularity in ED research,
rats have seldom been used to investigate the ED
associated with AS due to inherent tolerability to
high-cholesterol diet. This intimal priming method
caused to elicit multiple pelvic AS within 6 weeks,
facilitating the use of rats as a potential animal
model for AS. According to our previous studies,
these rats showed evidence of mild to moderate
pelvic AS and ED.
16
In vivo assessment of erectile function and tissue
procurement
After 6 weeks, all rats in both groups underwent
cavernosometry during cavernous nerve stimula-
tion, as described previously.
16,17 The stimulation
parameters were 3V at varying frequencies of 2.5–
20Hz with square wave duration of 0.2ms for 50s.
Both mean arterial pressure (MAP) and intracaver-
nosal pressure (ICP) were continuously monitored
during the electrical stimulation. Comparisons of
the (1) ICP/MAP and (2) area under curve (AUC)
corresponding to the duration of electrical stimula-
tion were carried out.
At the end of the experiment, blood samples
were collected from the jugular vein, centrifuged at
1500g for 20min at 41C, and plasma was stored at
 701C for biochemical assays. The penis was
excised, the penile shaft was separated from the
crura and a 2–3mm transversal slice was cut just
distal to the point of contact of both crura.
The segments were maintained in 4% formaldehyde
solution for immunohistochemistry. The remaining
proximal crural segment was dissected out and
then immediately frozen in liquid nitrogen and
stored at  801C.
Immunoblot for cavernous ADMA
Homogenized cavernosal strips containing ice-cold
buffer (20mM Tris-HCl (pH 7.4), 2.5mM EDTA, 1%
Triton X-100, 1% sodium deoxycholate, 0.1% SDS,
50mM NaF, 10mM Na4P2O7,1 m M Na3VO4 and 1%
phenylmethylsulfonyl fluoride) were centrifuged at
10000g for 20min to remove insoluble material.
The protein concentration was determined by the
bicinchoninic acid protein assay (Pierce, Rockford,
IL, USA).
An equal volume (50mg) of samples was then
loaded and run on a 10% polyacrylamide gel and
transferred to a nitrocellulose membrane, which was
subsequently probed with mouse monoclonal anti-
body against ADMA (Upstate Biotechnologies, Lake
Placid, NY, USA); this was followed by addition of
horseradish peroxidase-conjugated secondary anti-
bodies. Peroxidase-conjugated anti-rabbit IgG anti-
bodies using the enhanced chemiluminescence
system (Amersham Biosciences, Piscataway, NJ,
USA) detected the bound antibodies. To adjust for
loading differences, we reprobed the membranes
with an antibody against glyceraldehyde-3-phos-
phate dehydrogenase (GAPDH). The tissue amount
of ADMA was quantified by densitometry (Image-
Pro plus; Media Cybernetics, Bethesda, MD, USA).
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isoforms
Tissue sections (5mm) were deparaffinized, rehy-
drated and fixed with methanol  0.3% hydrogen
peroxide at room temperature for 30min. Tissue
sections were blocked with 100 diluted antigen
unmasking solution (Vector Laboratories, Burlin-
game, CA, USA) for 3min and incubated with
rodent block (Lab Vision, Fremont, CA, USA) for
1h at room temperature, followed by overnight
incubation with a primary goat polyclonal antibody
against DDAH 1 or a mouse monoclonal antibody
against DDAH 2 (1:50 dilution) overnight. Sections
were incubated sequentially with biotinylated anti-
body (goat anti-rabbit IgG) and horseradish strepta-
vidin (Santa Cruz Biotechnology, Santa Cruz, CA,
USA) for 1h at room temperature at each step. The
samples were then incubated with diaminobenzi-
dine using the DAB Substrate System (Lab Vision)
and counterstained with hematoxylin, which
stained all cell nuclei bluish, whereas DDAH 1-
and DDAH 2-positive cells stained brown.
Four sections ( 400) from each animal were
assessed, and the mean immunostaining score in
endothelial, smooth muscle and nerve was calcu-
lated. Each section was scored blind as follows: 0,
no staining; 1, slightly stained; 2, moderately
stained and 3, strongly stained.
Measurement of cavernous NOS and DDAH activity
To determine the constitutive NOS activity, we used
a commercial kit for the NOS assay (Calbiochem-
Novabiochem Corp., La Jolla, CA, USA) for assaying
the conversion of L-arginine to L-citrulline in the
cavernous homogenates. To determine the iNOS
activity in the penile samples, we repeated the
above-mentioned experiments under calcium-free
conditions.
We assayed DDAH activity by determining
L-citrulline formation in cavernous tissue homoge-
nates, as previously described in pulmonary
tissues.
18 The cavernosal samples were homo-
genized in a medium containing 0.1 M sodium
phosphate buffer (pH 6.5), 1mM PMSF, 1mM pep-
statin A and 2mM leupeptin. The homogenate was
centrifuged and the supernatant was collected. The
reaction mixture consisted of 90ml of supernatant,
1mmoll
 1 ADMA, 20mM EDTA and 0.1 M sodium
phosphate buffer (pH 6.5). The samples were
incubated for 2h and the reaction was stopped by
10% trichloroacetic acid. For the negative controls,
homogenates were boiled for 10min to inactivate the
enzyme, and the resultant background values were
subtracted from the experimental data to determine
the genuine DDAH activity. Then the supernatant
was incubated with diacetyl monoxime (0.8%) and
antipyrine (0.5%) at 601C for 110min. The amount
of L-citrulline was determined by spectrophoto-
metric analysis at 466nm. One unit of DDAH
activity was expressed as the amount that catalyzed
the formation of 1mmol citrulline from ADMA per
minute at 371C.
Both the NOS and DDAH activities are normalized
by the protein contents of the cavernosal tissue and
expressed as citrulline production in pmol per min
mg protein.
Determination of lipid peroxidation of cavernosal
tissue with the malondialdehyde assay
To measure the lipid peroxidation in cavernosal
tissue, we used an malondialdehyde (MDA)-586
colorimetric assay kit (OXIS International, Portland,
OR, USA) as previously described.
19 The degree of
lipid peroxidation was determined by an MDA
standard curve as the expressed MDA equivalent
content (nmol MDA per ml).
Statistical analysis
All data are means±s.e. Spearman’s correlation
coefficients were obtained to evaluate the relation-
ship between surrogate markers of erectile function
(ICP/MAP and AUC) and cavernosal ADMA level.
Differences between the groups were assessed by the
Student’s t-test with a P-value o0.05 regarded to be
significant.
Results
Comparison of erectile function
Before electrostimulation, measurement of MAP
revealed higher MAP in AS group than Con group
(120±6 vs 102±4, P¼0.02) but comparison of
baseline ICP/MAP was not different between them
(12.1±4.6 in AS group vs 14.7±4.2 in Con group,
P¼0.16). During cavernous nerve stimulation, the
AS group had lower ICP/MAP and AUC than the
Con group (Figure 1). Comparison of both indices
between the two groups revealed a significant
difference at 5–20Hz (Po0.05).
Immunoblots for the measurement of cavernosal
ADMA
Tissue levels of ADMA were semiquantitatively
measured by western blot assay. As shown in
Figure 2, the penile tissue of the AS group had
greater amount of ADMA than the Con group.
Densitometry revealed a more than three times
higher density of ADMA in the AS group. In As
group, the Spearman’s correlation coefficient indi-
cated a moderate but significant negative correlation
between surrogate markers of erectile function and
the ADMA expression (r¼ 0.43 for ICP/MAP,
DDAH in rat penile tissue
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tailed)¼0.03).
Immunohistochemical staining for DDAH isoforms
Immunohistochemical localization of DDAH iso-
forms within the rat penile tissue is shown in
Figure 3. Immunoreactivity for DDAH 1 was seen in
the cytoplasm of trabecular smooth muscle, en-
dothelium and neural tissue, but only the modest
endothelial staining was observed for DDAH 2. The
expression of DDAHs was not affected by the
presence of pelvic AS. Comparison of the mean
immunostaining score revealed no significant dif-
ference in the isoforms was noted between the AS
and Con groups.
Cavernous NOS/DDAH activity
Comparatively lower constitutive NOS and DDAH
activity was found in the AS group (Figure 4).
Compared to Con group, the constitutive NOS and
DDAH activity was reduced up to 54 and 37% in AS
group, respectively.
ELISA for cavernosal MDA
The enzyme-linked immunosorbent assay (ELISA)
revealed a higher cavernosal level of MDA in AS
group compared to the Con group (28.6±5.7 vs
55.8±4.9, Po0.001).
Discussion
The salient findings from the present study on rats
with pelvic AS are the following: (1) elevation of
cavernosal ADMA expression in AS group and
demonstration of a negative correlation between
erectile function in the AS group and cavernosal
ADMA expression; (2) histological confirmation of
the expression of both isoforms of DDAH, respon-
sible for the metabolism of ADMA in rat cavernosal
tissue and (3) the association of reduced DDAH
activity in the AS group with decreased NOS
activity, which may lead to decreased erectile
function. These results highlight the negative func-
tion of ADMA on erectile function in the presence of
systemic AS, and confirmed the presence of a
functional ADMA clearance system in rat penile
tissue.
Along with the inhibitory pressure response to
pelvic nerve stimulation following intracavernosal
ADMA administration, the demonstration of a more
than three times higher cavernosal accumulation of
ADMA, in rats with AS compared to the controls,
supports a claim of possible anti-erectile function of
cavernosal ADMA in the presence of pelvic AS.
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Figure 2 Expression of cavernosal asymmetric dimethylarginine (ADMA) in control (Con) and atherosclerosis (AS) rats (a)
representative immunoblot (b) relative expression of ADMA after adjusted by the expression of glyceraldehyde-3-phosphate
dehydrogenase (GAPDH). Asterisk (*) denotes statistical significance (Po0.05).
2500
2000
1500
1000
500
0
Con
As
80
70
60
50
40
30
20
10
0
*
*
*
*
*
I
C
P
/
M
A
P
 
(
%
)
A
r
e
a
 
u
n
d
e
r
 
c
u
r
v
e
(
m
m
H
g
s
e
c
)
2.5Hz 5Hz 10Hz 20Hz 2.5Hz 5Hz 10Hz 20Hz
Figure 1 Results of cavernosometry (3V, 0.2ms, 50s). Comparison of intracavernosal pressure/mean arterial pressure (ICP/MAP) (a) and
area under curve (b) between normal control (Con) and atherosclerosis (AS) groups showed significant impairment of erectile response in
the AS group at higher frequencies. Asterisk (*) denotes statistical significance (Po0.05).
DDAH in rat penile tissue
K Park et al
231
International Journal of Impotence ResearchSeveral human studies have associated plasma
ADMA levels with ED in patients with CAD.
12,13
Elevated plasma ADMA reduces systemic NO
bioactivity, leading to systemic as well as coronary
endothelial dysfunction in patients with ED.
20 On
the basis of human data, it is reasonable to speculate
that the elevated plasma ADMA levels interfere with
the erectile response due to systemic endothelial
dysfunction. However, the demonstration of caver-
nosal ADMA accumulation, after bilateral clamping
of the internal iliac arteries, has suggested the
possibility that increased levels of local ADMA
might directly cause alteration of the erectile
function by inhibiting the local NOS system.
15 Our
data on rats with AS supports the potential function
of cavernosal ADMA accumulation in the develop-
ment of ED. Future study is needed to determine the
potential contribution of the local accumulation of
ADMA to erectile function and to investigate
whether the treatment aimed at lowering ADMA,
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Figure 3 Immunohistochemical evaluation of both dimethylarginine dimethylaminohydrolase (DDAH) isoforms in rat cavernosal
tissues. Immunoreactivities are seen in brown. Upper two rows revealed representative pictures from normal control (Con) and
atherosclerosis (AS) groups. Compared to DDAH 2, which showed only modest endothelial staining (arrow), DDAH 1 showed a greater
staining intensity and was found in both endothelial (arrow) and trabecular smooth muscle (arrowhead). Representative neural picture in
third row was from Con group. Similar findings were observed in AS group, so only pictures from Con group were displayed. Abundant
staining for DDAH 1 was identified in neural cells, whereas no immunostaining was observed for DDAH 2. Comparison of staining scores
showed similar staining intensity of both isoforms in the Con and AS groups, as shown in densitometry.
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function.
Despite the presence of several reports linking
ADMA with ED, the mechanism associated with
ADMA elevation has not been sufficiently explored.
In other parts of the body, DDAH has been identified
as the main metabolic pathway of ADMA. By
western blot analysis, Japanese researchers have
previously found both isoforms in the penile tissue
of rabbits.
9 Our immunohistochemical experiments
confirmed this in the rat. In addition, although both
isoforms were identified, type 1 showed a higher
and wider immunoreactivity than did type 2 in the
cavernosum of the rat. This does not necessarily
mean that type 1 has a more significant functional
function than type 2. However, the modest immu-
noreactivity of type 2 in the endothelial cells may
indicate a limited function of type 2 DDAH in the
penile erections of rats. Further study using trans-
genic animals is needed to clarify this.
Our study revealed no change in DDAH expres-
sion by immunohistochemistry. The DDAH activity
was significantly attenuated in the AS rats. More-
over, the decreased DDAH activity was associated
with the NOS activity, which has been shown to be a
functional correlate of erectile function.
21 Thus,
diminished cavernosal DDAH activity might be
one of the potential causes of impaired erectile
function. The finding of decreased DDAH activity
has been consistently found in models of diabetes,
hyperhomocysteinemia and AS, where endothelial
dysfunction has a critical pathological func-
tion.
11,22,23 Because decreased bioactivity of NO is
the most crucial feature of endothelial dysfunction,
as well as ED, lowered DDAH activity might result
in ADMA accumulation, leading to diminished NO
production and subsequent endothelial and ED in
AS rats.
Reactive oxygen species has been regarded as a
possible cause of endothelial and ED; increased
oxidative stress is often regarded as one of the
initiating events of the development of AS.
24 In this
study, we observed increased MDA levels in the
cavernosal tissue of AS rats. Interestingly, increased
oxidative stress is known to be a strong inhibitor of
DDAH. A recent study has identified highly reactive
cysteine residues (Cys 249) at the active site of
DDAH; its sulfhydryl group predisposes DDAH to
easy oxidation or nitrosation after which it loses its
activity.
25 The antioxidants polyethylene glycol-
conjugated superoxide dismutase and pyrrolidine
dithiocarbamate have been recently reported to
preserve DDAH activity.
11,22 These studies indicate
that DDAH activity could be modulated by cardio-
vascular risk factors in a reactive oxygen species-
sensitive manner.
Although we have demonstrated the presence of
both isoforms, we have not clarified the functional
function of each isoform in rat penile erections. Use
of isoform-specific inhibitor or transgenic animals
might elucidate their individual functions. The
change of expression, location and activity, for
various causes of ED, should be further investigated
to identify its pathophysiology.
In conclusion, the results of this study demon-
strated that increased cavernosal ADMA levels were
associated with ED in a rat model of AS. Further-
more, suppression of DDAH activity was associated
with increased cavernosal ADMA accumulation
leading to decreased NOS activity and impairment
of rat penile erections. Increased oxidative stress in
the cavernosal tissue of rats might contribute to the
diminished DDAH activity.
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